Kathryn M. Thrailkill

4.4k citations

75 papers · 3.5k indexed · h-index 36

Molecular Biology top 5%
Endocrinology, Diabetes and Metabolism top 1%
Orthopedics and Sports Medicine top 1%
Genetics top 5%
Oncology top 5%

Co-authors: John L. Fowlkes R. Clay Bunn Charles K. Lumpkin Gael Cockrell Stephen F. Kemp Hideaki Nagase Elizabeth C. Wahl Delila Serra
Topics: Growth Hormone and Insulin-like Growth Factors (28 papers)Metabolism, Diabetes, and Cancer (18 papers)Bone Metabolism and Diseases (12 papers)
Cited by: Orthopedics and Sports Medicine Endocrinology, Diabetes and Metabolism Nephrology
Journals: Journal of Biological Chemistry The Journal of Clinical Endocrinology & Metabolism Diabetes Care
Partner nations: United States United Kingdom Denmark

In The Last Decade

Kathryn M. Thrailkill

75 papers receiving 3.4k citations

Peers

Countries citing papers authored by Kathryn M. Thrailkill

Since Specialization

Citations

This map shows the geographic impact of Kathryn M. Thrailkill's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kathryn M. Thrailkill with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kathryn M. Thrailkill more than expected).

Fields of papers citing papers by Kathryn M. Thrailkill

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kathryn M. Thrailkill. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kathryn M. Thrailkill. The network helps show where Kathryn M. Thrailkill may publish in the future.

Co-authorship network of co-authors of Kathryn M. Thrailkill

This figure shows the co-authorship network connecting the top 25 collaborators of Kathryn M. Thrailkill. A scholar is included among the top collaborators of Kathryn M. Thrailkill based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kathryn M. Thrailkill. Kathryn M. Thrailkill is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Canagliflozin, an SGLT2 inhibitor, corrects glycemic dysregulation in TallyHO model of T2D but only partially prevents bone deficits 2020 ·Bone ·Kathryn M. Thrailkill,R. Clay Bunn,Sasidhar Uppuganti,(unknown),Iuliana Popescu,Evangelia Kalaitzoglou,John L. Fowlkes,Jeffry S. Nyman	14
2	Constitutive activation of MEK1 in osteoprogenitors increases strength of bone despite impairing mineralization 2019 ·Bone ·John L. Fowlkes,R. Clay Bunn,(unknown),Evangelia Kalaitzoglou,Sasidhar Uppuganti,Mustafa Ünal,Jeffry S. Nyman,Kathryn M. Thrailkill	8
3	Preserving and restoring bone with continuous insulin infusion therapy in a mouse model of type 1 diabetes 2017 ·Bone Reports ·Jeffry S. Nyman,Evangelia Kalaitzoglou,R. Clay Bunn,Sasidhar Uppuganti,Kathryn M. Thrailkill,John L. Fowlkes	28
4	The impact of SGLT2 inhibitors, compared with insulin, on diabetic bone disease in a mouse model of type 1 diabetes 2016 ·Bone ·Kathryn M. Thrailkill,Jeffry S. Nyman,R. Clay Bunn,Sasidhar Uppuganti,Katherine Thompson,Charles K. Lumpkin,Evangelia Kalaitzoglou,John L. Fowlkes	56
5	SGLT2 inhibitor therapy improves blood glucose but does not prevent diabetic bone disease in diabetic DBA/2J male mice 2015 ·Bone ·Kathryn M. Thrailkill,R. Clay Bunn,Jeffry S. Nyman,Mallikarjuna Rettiganti,Gael Cockrell,Elizabeth C. Wahl,Sasidhar Uppuganti,Charles K. Lumpkin,John L. Fowlkes	63
6	Insulin Pump Therapy Started at the Time of Diagnosis: Effects on Glycemic Control and Pancreatic β-Cell Function in Type 1 Diabetes 2011 ·Diabetes Technology & Therapeutics ·Kathryn M. Thrailkill,Cynthia Moreau,Christopher J. Swearingen,(unknown),(unknown),(unknown),Stephen F. Kemp,J. Paul Frindik,John L. Fowlkes	21
7	Increasing duration of type 1 diabetes perturbs the strength–structure relationship and increases brittleness of bone 2010 ·Bone ·Jeffry S. Nyman,Jesse L. Even,Chan‐Hee Jo,Erik G. Herbert,(unknown),Gael Cockrell,Elizabeth C. Wahl,R. Clay Bunn,Charles K. Lumpkin,John L. Fowlkes,Kathryn M. Thrailkill	89
8	Disease and gender-specific dysregulation of NGAL and MMP-9 in type 1 diabetes mellitus 2010 ·Endocrine ·Kathryn M. Thrailkill,Cynthia Moreau,Gael Cockrell,Chan‐Hee Jo,R. Clay Bunn,(unknown),Charles K. Lumpkin,John L. Fowlkes	57
9	Direct bone formation during distraction osteogenesis does not require TNFα receptors and elevated serum TNFα fails to inhibit bone formation in TNFR1 deficient mice 2009 ·Bone ·Elizabeth C. Wahl,James Aronson,Lichu Liu,Robert A. Skinner,(unknown),Gael Cockrell,John L. Fowlkes,Kathryn M. Thrailkill,R. Clay Bunn,Martin J. J. Ronis,Charles K. Lumpkin	15
10	Matrix metalloproteinases: their potential role in the pathogenesis of diabetic nephropathy 2008 ·Endocrine ·Kathryn M. Thrailkill,R. Clay Bunn,John L. Fowlkes	154
11	Severe deficiencies of IGF-I, IGF-II, IGFBP-3, ALS and paradoxically high-normal bone mass in a child with insulin-resistance syndrome (Rabson-Mendenhall type) 2007 ·Growth Hormone & IGF Research ·John L. Fowlkes,R. Clay Bunn,Hannah Coleman,Bryan D. Hall,(unknown),Kathryn M. Thrailkill	7
12	A novel rat model for the study of deficits in bone formation in type-2 diabetes 2007 ·Acta Orthopaedica ·Zhendong Liu,James Aronson,Elizabeth C. Wahl,Lichu Liu,Daniel S. Perrien,(unknown),John L. Fowlkes,Kathryn M. Thrailkill,R. Clay Bunn,Gael Cockrell,Robert A. Skinner,Charles K. Lumpkin	40
13	Investigational agents for the treatment of growth hormone-insensitivity syndrome 2006 ·Expert Opinion on Investigational Drugs ·Stephen F. Kemp,Kathryn M. Thrailkill	2
14	Regulation of Insulin-Like Growth Factor (IGF)-I Action by Matrix Metalloproteinase-3 Involves Selective Disruption of IGF-I/IGF-Binding Protein-3 Complexes 2003 ·Endocrinology ·John L. Fowlkes,Delila Serra,R. Clay Bunn,Kathryn M. Thrailkill,Jan J. Enghild,Hideaki Nagase	56
15	MMPs Are IGFBP‐Degrading Proteinases: Implications for Cell Proliferation and Tissue Growth 1999 ·Annals of the New York Academy of Sciences ·John L. Fowlkes,(unknown),Hideaki Nagase,Kathryn M. Thrailkill	41
16	Characterization of matrix metalloproteinases in human urine: alterations during adolescence 1999 ·Pediatric Nephrology ·Kathryn M. Thrailkill,(unknown),Carlyn K. Rosenberg,Kathy J. Auten,John L. Fowlkes	24
17	Differentiation of MC3T3-E1 Osteoblasts is associated with temporal changes in the expression of IGF-I and IGFBPs 1995 ·Bone ·Kathryn M. Thrailkill,Suresh Siddhanti,John L. Fowlkes,L. Darryl Quarles	42
18	Cyclic AMP as a second messenger for prorenin release from human decidual cells 1991 ·Placenta ·Alan Poisner,Kathryn M. Thrailkill,Stuart Handwerger,R. Poisner	18
19	Three Distinct Forms of Insulin-Like Growth Factor Binding Proteins are Released by Decidual Cells in Culture* 1990 ·Endocrinology ·David R. Clemmons,Kathryn M. Thrailkill,(unknown),Walker H. Busby	49
20	Decidual Prolactin (PRL)-Releasing Factor Stimulates the Synthesis of PRL from Human Decidual Cells* 1988 ·Endocrinology ·Avraham Golander,Randall G. Richards,Kathryn M. Thrailkill,(unknown),DELORIS C. ROGERS,Stuart Handwerger	15

About Kathryn M. Thrailkill

Kathryn M. Thrailkill is a scholar working on Endocrinology, Diabetes and Metabolism, Orthopedics and Sports Medicine and Nephrology, having authored 75 papers that have together received 3.5k indexed citations. Recurring topics across this work include Growth Hormone and Insulin-like Growth Factors (28 papers), Metabolism, Diabetes, and Cancer (18 papers) and Bone Metabolism and Diseases (12 papers). The work is most often cited by research in Orthopedics and Sports Medicine (643 citations), Endocrinology, Diabetes and Metabolism (1.2k citations) and Nephrology (305 citations). Kathryn M. Thrailkill has collaborated with scholars based in United States, United Kingdom and Denmark. Frequent co-authors include John L. Fowlkes, R. Clay Bunn, Charles K. Lumpkin, Gael Cockrell, Stephen F. Kemp, Hideaki Nagase, Elizabeth C. Wahl, Delila Serra, Cynthia Moreau and Evangelia Kalaitzoglou. Their work appears in journals such as Journal of Biological Chemistry, The Journal of Clinical Endocrinology & Metabolism and Diabetes Care.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact